QUADSMaster December 27, 2022 Nanoparticles to treat aging and age-related diseases – interview with Louis Hawthornes
QUADSMaster December 17, 2022 Targeting the immune system to extend healthspan – interview with Dr. Hans Keirstead
January 4, 2023 Our portfolio company, Immunis, announced the first-in-human injection of its stem cell secretome product to treat age and disease-related immune decline
January 4, 2023 Our portfolio company, Immunis, announced the first-in-human injection of its stem cell secretome product to treat age and disease-related immune decline